Carbamyl uracil derivative and application thereof

A technology of carbamoyluracil and derivatives, which is applied in the field of carbamoyluracil derivatives, and can solve the problems that anti-inflammatory and analgesic drugs have not been reported yet

Inactive Publication Date: 2016-04-20
XIAMEN INST OF RARE EARTH MATERIALS
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] So far, various types of FAAH inhibitors or NAAA inhibitors have been reported, but anti-inflammatory and analgesic drugs...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbamyl uracil derivative and application thereof
  • Carbamyl uracil derivative and application thereof
  • Carbamyl uracil derivative and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Embodiment 1. compound general synthetic method

[0058] Dissolve uracil derivative (10mmol) and 4-dimethylaminopyridine (0.5mmol) in pyridine (20mL), heat up to 60°C, slowly add isocyanate (20mmol) dropwise, and react at this temperature for 5h. Pyridine was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography to obtain the product.

Embodiment 2

[0059] Embodiment 2. Synthesis of compound 2.1

[0060] As described in Example 1, compound 2.1 was prepared, and the characterization data were as follows: IR (film) v max :2914,2844,1777,1701,1582,1486,1387cm -1 ; 1 HNMR (400MHz, CDCl 3 )δ0.86(t, J=6.8Hz, 3H), 1.23-1.28(m, 6H), 1.47-1.52(m, 2H), 3.24-3.29(m, 2H), 5.79(d, J=8.4Hz ,1H),8.20(d,J=8.4Hz,1H),9.11(t,J=5.2Hz,1H),11.70(s,1H)ppm; 13 CNMR (100MHz, CDCl 3 )δ14.3,22.5,26.3,29.1,31.3,40.8,104.0,139.2,150.4,152.0,163.3ppm; MS(ESI,m / z):238(M-H) - ;Anal.calcdforC 11 h 17 N 3 o 3 :C,55.22;H,7.16;N,17.56;Found:C,55.06;H,7.15;N,17.59.

Embodiment 3

[0061] Embodiment 3. Synthesis of compound 2.2

[0062] As described in Example 1, compound 2.2 was prepared, and the characterization data were as follows: IR (film) v max :3079,2914,2844,1750,1700,1570,1486,1387cm -1 ; 1 HNMR (400MHz, CDCl 3 )δ0.89(t, J=6.8Hz, 3H), 1.29-1.38(m, 6H), 1.59-1.62(m, 2H), 1.99(d, J=1.2Hz, 3H), 3.35-3.40(m ,2H),8.24(q,J=1.2Hz,1H),8.60(s,1H),9.09(br,1H)ppm; 13 CNMR (100MHz, CDCl 3 )δ12.4,14.0,22.5,26.5,29.2,31.4,41.2,112.3,134.6,150.0,151.5,163.0ppm; MS(ESI,m / z):252(M-H) - ;Anal.calcdforC 12 h 19 N 3 o3 : C, 56.90; H, 7.56; N, 16.59; Found: C, 57.08; H, 7.55; N, 17.02.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a carbamyl uracil derivative and application thereof. The structural formula of the derivative is as shown in the description. The derivative is a novel compound with the endogenous cannabinoid hydrolase inhibiting function, and a new method is provided for inflammation and pain treatment.

Description

technical field [0001] The invention belongs to the technical field of medical organic chemistry, and specifically relates to a carbamoyluracil derivative and an application thereof. Background technique [0002] Tetrahydrocannabinol (Tetrahydrocannabinol, THC for short) acts on receptors of cannabinoid receptor type 1 or type 2 (cannabinoid receptor 1 / 2, CB1 or CB2 for short). The discovery prompted scientists to investigate endogenous ligands for cannabinoid receptors. N-arachidonoyldopamine (N-arachidonoyldopamine) and other endocannabinoids have been found to act on cannabinoid receptors. . Like lipid transmitters such as prostaglandins, these endocannabinoids do not accumulate in the body, but are synthesized locally on demand, and are regulated by enzymes and receptors, and can be metabolized into corresponding cannabinoids by their specific hydrolytic enzymes. Fatty acids and substances such as ethanolamine and glycerin, thereby reducing the effect of such substanc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D239/54C07D239/553C07D239/557C07D239/545C07D239/60C07D403/06C07D401/06A61P29/00A61P25/00A61P25/02A61P25/06A61P19/02A61P11/06A61P11/00A61P11/02A61P17/06A61P17/00A61P1/04A61P1/00
CPCC07D239/54C07D239/545C07D239/553C07D239/557C07D239/60C07D401/06C07D403/06
Inventor 李宇航邱彦杨隆河任杰张洋李燕婷陈玲朱程刚卢灿忠
Owner XIAMEN INST OF RARE EARTH MATERIALS
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products